Luisa Beltran
Markets
Trusts/Funds/Financial Vehicles
Legal Services
Business/Consumer Services
Financial Services
Investing/Securities
Brown
Christopher
Joshua Thompson
Rob Brown
North America
United States
Political/General News
Respiratory Tract Diseases
Health
Medical Conditions
Outbreaks/Epidemics
Novel Coronaviruses
Infectious Diseases
I/IAV
M/CYC
M/FCL
N/DJN
N/GEN
N/HLT
N/NWS
N/WER
R/NME
R/US
SHT.XX
Barrons.com
Barrons Blogs
Wires
DJIA
Dow Jones Industrial Average
CODES_REVIEWED
Alternative Investments
Coronavirus
Markets
Private Equity
author
Luisa Beltran
author|Luisa Beltran
name
Luisa Beltran
extractedtext
Luisa Beltran
rank
1
codetype
author
code
luisa_beltran
nameformat
surname_first
author
Luisa Beltran
id
Luisa Beltran
topicid
barrons_display_subject
BARMKTS
barrons_display_subject|BARMKTS
codetype
BARRONS_DISPLAY_SUBJECT
canbedisplaysubject
true
value
BARMKTS
source
MANUAL
status
modified
name
Markets
code
BARMKTS
djn
SHT.XX
djn|SHT.XX
significance
prominent
name
SHT.XX
why
about
source
FACTIVA
occurs
true
fcode
SHT.XX
codetype
djn
code
sht_xx
onlinesignificance
prominent
djn
M/FCL
djn|M/FCL
name
M/FCL
why
lineage
source
FACTIVA
fcode
M/FCL
codetype
djn
code
m_fcl
djn
I/IAV
djn|I/IAV
name
I/IAV
why
lineage
source
FACTIVA
fcode
I/IAV
codetype
djn
code
i_iav
djn
M/CYC
djn|M/CYC
name
M/CYC
why
lineage
source
FACTIVA
fcode
M/CYC
codetype
djn
code
m_cyc
djn
N/NWS
djn|N/NWS
significance
prominent
name
N/NWS
why
about
source
FACTIVA
fcode
N/NWS
codetype
djn
code
n_nws
onlinesignificance
prominent
djn
N/GEN
djn|N/GEN
name
N/GEN
why
lineage
source
FACTIVA
fcode
N/GEN
codetype
djn
code
n_gen
djn
N/HLT
djn|N/HLT
name
N/HLT
why
lineage
source
FACTIVA
fcode
N/HLT
codetype
djn
code
n_hlt
djn
R/US
djn|R/US
significance
prominent
name
R/US
why
about
source
FACTIVA
fcode
R/US
codetype
djn
code
r_us
onlinesignificance
prominent
djn
R/NME
djn|R/NME
name
R/NME
why
lineage
source
FACTIVA
fcode
R/NME
codetype
djn
code
r_nme
djn
N/DJN
djn|N/DJN
codetype
djn
value
N/DJN
source
DJN-CONTROL
status
modified
inactivebydefault
true
name
N/DJN
code
n_djn
djn
N/WER
djn|N/WER
codetype
djn
value
N/WER
source
DJN-CONTROL
status
modified
inactivebydefault
true
name
N/WER
code
n_wer
first_publish_headline
Deal Making Is Drying Up — and It Won’t Get Better Soon
first_publish_headline|Deal Making Is Drying Up — and It Won’t Get Better Soon
flow
NWREGULAR
flow|NWREGULAR
codetype
FLOW
value
NWREGULAR
source
MANUAL
status
modified
name
Wires
code
NWREGULAR
flow
Barrons.com
flow|Barrons.com
codetype
FLOW
value
Barrons.com
source
MANUAL
status
modified
name
Barrons.com
code
online
name
Online
title
Product
code
Barrons.com
flow
Barrons Blogs
flow|Barrons Blogs
codetype
FLOW
value
Barrons Blogs
title
Product
source
MANUAL
status
modified
name
Barrons Blogs
code
Barrons_Blogs
headline
Deal Making Is Drying Up — and It Won’t Get Better Soon
headline|Deal Making Is Drying Up — and It Won’t Get Better Soon
in
i81502
in|i81502
significance
prominent
name
Trusts/Funds/Financial Vehicles
why
about
source
FACTIVA
fcode
i81502
codetype
in
code
i81502
onlinesignificance
prominent
in
ifinal
in|ifinal
name
Financial Services
why
lineage
source
FACTIVA
fcode
ifinal
codetype
in
code
ifinal
in
iinv
in|iinv
name
Investing/Securities
why
lineage
source
FACTIVA
fcode
iinv
codetype
in
code
iinv
in
i835
in|i835
name
Legal Services
why
association
source
FACTIVA
fcode
i835
codetype
in
code
i835
in
ibcs
in|ibcs
name
Business/Consumer Services
why
lineage
source
FACTIVA
fcode
ibcs
codetype
in
code
ibcs
index
Dow Jones Industrial Average
index|Dow Jones Industrial Average
symbol
DJIA
country
US
codetype
index
displayname
Dow Jones Industrial Average
extractedtext
Dow Jones Industrial Average
source
MANUAL
code
djia
name
Dow Jones Industrial Average
significance
prominent
exchange
Dow Jones Global
exchangeisocode
DOW JONES GLOBAL
chartingsymbol
INDEX/US/DOW JONES GLOBAL/DJIA
status
modified
onlinesignificance
prominent
index
DJIA
index|DJIA
name
Dow Jones Industrial Average
background-info
BRIEFING-BOOK
significance
PROMINENT
media
media-2
media|media-2
responsive
layout
wrap
softcrop
Horizontal
imphotoid
im-165740
location
https://images.barrons.com/im-165740/?size=1.5
media
media-1
media|media-1
softcrop
Horizontal
imphotoid
im-165740
location
https://images.barrons.com/im-165740/?size=1.5
ns
gsars
ns|gsars
significance
prominent
name
Novel Coronaviruses
why
about
source
FACTIVA
fcode
gsars
codetype
ns
code
gsars
onlinesignificance
prominent
ns
gout
ns|gout
significance
prominent
name
Outbreaks/Epidemics
why
about
source
FACTIVA
fcode
gout
codetype
ns
code
gout
onlinesignificance
prominent
ns
gcat
ns|gcat
name
Political/General News
why
lineage
source
FACTIVA
fcode
gcat
codetype
ns
code
gcat
ns
gcold
ns|gcold
name
Respiratory Tract Diseases
why
lineage
source
FACTIVA
fcode
gcold
codetype
ns
code
gcold
ns
ghea
ns|ghea
name
Health
why
lineage
source
FACTIVA
fcode
ghea
codetype
ns
code
ghea
ns
gmed
ns|gmed
name
Medical Conditions
why
lineage
source
FACTIVA
fcode
gmed
codetype
ns
code
gmed
ns
gspox
ns|gspox
name
Infectious Diseases
why
lineage
source
FACTIVA
fcode
gspox
codetype
ns
code
gspox
nwchain
SB503209352039206146753045862998127253179941
nwchain|SB503209352039206146753045862998127253179941
pe
Brown
pe|Brown
lastname
Brown
displayname
Brown
name
Brown
extractedtext
Brown
source
FACTIVA
codetype
pe
code
brown
nameformat
surname_first
pe
Christopher
pe|Christopher
firstname
Christopher
displayname
Christopher
name
Christopher
extractedtext
Christopher
source
FACTIVA
codetype
pe
code
christopher
nameformat
surname_first
pe
Joshua Thompson
pe|Joshua Thompson
firstname
Joshua
lastname
Thompson
displayname
Thompson, Joshua
name
Joshua Thompson
extractedtext
Joshua Thompson
source
FACTIVA
codetype
pe
code
joshua_thompson
nameformat
surname_first
pe
Rob Brown
pe|Rob Brown
firstname
Rob
lastname
Brown
displayname
Brown, Rob
name
Rob Brown
extractedtext
Rob Brown
source
FACTIVA
codetype
pe
code
rob_brown
nameformat
surname_first
re
usa
re|usa
significance
prominent
name
United States
why
about
source
FACTIVA
subcat
cntry
fcode
usa
codetype
re
code
usa
onlinesignificance
prominent
re
namz
re|namz
name
North America
why
lineage
source
FACTIVA
subcat
snr
fcode
namz
codetype
re
code
namz
relay
SYND
relay|SYND
name
Syndication
source
EXPANDER
value
SYND
codetype
RELAY
code
synd
status
modified
statistic
CODES_REVIEWED
statistic|CODES_REVIEWED
name
CODES_REVIEWED
value
CODES_REVIEWED
codetype
STATISTIC
code
CODES_REVIEWED
subject
BARMKTS
subject|BARMKTS
ruleid
BARMKTS
codetype
SUBJECT
value
BARMKTS
selectable
true
canbedisplaysubject
true
name
Markets
title
Markets
status
modified
code
BARMKTS
subject
BARCORONA
subject|BARCORONA
ruleid
BARCORONA
codetype
SUBJECT
value
BARCORONA
canbedisplaysubject
true
name
Coronavirus
title
Coronavirus
status
modified
code
BARCORONA
subject
BARALTINV
subject|BARALTINV
ruleid
BARALTINV
codetype
SUBJECT
value
BARALTINV
selectable
true
canbedisplaysubject
true
name
Alternative Investments
title
Alternative Investments
status
modified
code
BARALTINV
subject
BARPRIEQ
subject|BARPRIEQ
ruleid
BARPRIEQ
codetype
SUBJECT
value
BARPRIEQ
canbedisplaysubject
true
name
Private Equity
title
Private Equity
status
modified
code
BARPRIEQ
wordcount
646
wordcount|646
id
facebook
id|facebook
news_tab_url
https://www.barrons.com/articles/deal-making-is-drying-up-and-it-wont-get-better-soon-51585909801
Photograph by William Thomas Cain/Getty Images
Deal Making Is Drying Up — and It Won’t Get Better Soon
Deal Making Is Drying Up — and It Won’t Get Better Soon
Deal Making Is Drying Up — and It Won’t Get Better Soon
The U.S. M&A market was cut in half during the first quarter of the year through March 28, and it is going to get worse before it gets better.
Deal Making Is Drying Up — and It Won’t Get Better Soon
The U.S. M&A market was cut in half during the first quarter of the year through March 28, and it is going to get worse before it gets better.
https://www.barrons.com/articles/m-a-deals-plunge-amid-the-coronavirus-crisis-51585681640
https://www.wsj.com/articles/coronavirus-throws-deal-making-into-disarray-11585652400
https://www.barrons.com/articles/the-dow-is-on-track-for-its-worst-first-quarter-heres-what-history-says-is-next-51585680975
mailto:luisa.beltran@dowjones.com
Deal Making Is Drying Up — and It Won’t Get Better Soon
By Luisa Beltran
Photograph by William Thomas Cain/Getty Images
The U.S. M&A market is going to get worse before it gets better as Covid-19 ravages the U.S. economy.
It’s already pretty bad. U.S. announced deal volume plunged 51% to $252.9 billion as of March 28, according to Refinitiv. Globally, the value of announced transactions fell 28% to $697.6 billion, while the number of transactions dropped 16%, the data provider said.
It’s going to get worse. Mergers could plunge another 50% to 80% in the second quarter as sellers wait to see if prices rebound, according to bankers and private equity executives Barron’s spoke to in an informal survey. Some even think transactions could fall to near zero as the M&A market waits for some sort of clarity, and for the stock market to find a bottom.
“The M&A market typically falls after a major correction in over inflated asset prices,” said Joshua Thompson, head of leveraged finance at law firm Shearman & Sterling.
The times certainly had been good for mergers and acquisitions, with many companies getting solid for high multiples, somes as high as 20 times earnings before interest, tax, depreciation and amortization. Covid-19 put a stop to that 10-year bull run for mergers, as the Dow Jones Industrial Average
tumbled to its worst quarterly loss since 1987.
Even that $252.9 billion figure for March mergers is misleading, because the number includes deals that were in process before Covid-19 decimated the U.S. stock market. The real test will come later in Q2 when transactions signed after the advent of Covid-19 try to close. The number of post-corona deals completed will likely be significantly fewer. Their size will also be lower because the market capitalizations of companies have dropped by 30% to 60%. “It’s not a good time to bring a good asset to market,” says Christopher Rile, an M&A partner with Ropes & Gray.
Covid-19 will likely cause problems for the nation’s investment banks. If mergers don’t rebound by the end of 2020, the downturn could result in layoffs. Smart IBs will look to cut pay instead of furloughing people, said Rob Brown, CEO of Lincoln International, a global middle market investment bank. Big bonuses, though, will likely be in short supply.
When the U.S. emerges from the covid-19 recession is unknown. Many hope covid-19 abates, travel returns and business resume operations by June to September. A worse case scenario sees the virus churning through the country, with workers staying home for the rest of the year.
The only sure thing is that the M&A market will return. At some point, distressed assets will start to come to market, said Ropes & Gray’s Rile says. And distressed investors, hedge funds and private equity firms are positioning themselves to take advantage of buying opportunities
Any M&A will likely include companies that need to sell, either because they’re underperforming or the parent doesn’t have funds to help them. Strategics that don’t need debt financing and are looking for scale may be on the hunt. “I think what goes down quickly tends to come up quickly,” Lincoln International’s Brown said . “We were all waiting for an economic correction anyway.”
Just not necessarily one like this.
Write to Luisa Beltran at luisa.beltran@dowjones.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.